Compare GKOS & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | VFC |
|---|---|---|
| Founded | 1998 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.6B |
| IPO Year | 2015 | 1994 |
| Metric | GKOS | VFC |
|---|---|---|
| Price | $141.22 | $19.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 18 |
| Target Price | ★ $126.92 | $18.24 |
| AVG Volume (30 Days) | 642.1K | ★ 6.2M |
| Earning Date | 04-29-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.72 |
| EPS | N/A | ★ 0.95 |
| Revenue | $507,442,000.00 | ★ $10,488,556,000.00 |
| Revenue This Year | $23.32 | N/A |
| Revenue Next Year | $27.43 | $2.06 |
| P/E Ratio | ★ N/A | $19.98 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $11.11 |
| 52 Week High | $145.50 | $22.27 |
| Indicator | GKOS | VFC |
|---|---|---|
| Relative Strength Index (RSI) | 73.45 | 51.34 |
| Support Level | $80.14 | $18.05 |
| Resistance Level | N/A | $20.40 |
| Average True Range (ATR) | 4.95 | 0.85 |
| MACD | 1.69 | -0.18 |
| Stochastic Oscillator | 86.28 | 24.04 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.